Life Time $702 million IPO
We advised the underwriters on the IPO and NYSE listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Emerson acquires control of Aspen Technology in $11 billion transaction
We are advising Emerson on the transaction
Supernus Pharmaceuticals $450 million acquisition of Adamas Pharmaceuticals
We are advising Lazard as financial adviser to Adamas
Genesis Capital sale to New Residential Investment
We are advising Genesis Capital and affiliates of Goldman Sachs on the transaction
XP acquisition of a minority stake in Jive Investments
We advised XP on the transaction
Manchester United secondary offering
We advised the underwriter on the SEC-registered stock offering
XP $9.5 billion combination involving Itaú Unibanco Holding’s XPart unit
We advised XP on the transaction
Enphys Acquisition Corp. $345 million IPO
We advised the underwriters on the SPAC IPO and NYSE listing
Nuvei $425 million U.S. IPO
We advised Nuvei on its U.S. IPO and Nasdaq listing of subordinate voting shares
Regions Bank acquires Sabal Capital Partners
We are advising Regions on the transaction